Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7408)
All Articles published online
|
Publishing Process of This Article
|
Sep 6, 2020 (publication date) through Mar 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Georgiev T, Angelov AK. Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression. World J Clin Cases 2020; 8(17): 3669-3678 [PMID: 32953843 DOI: 10.12998/wjcc.v8.i17.3669] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i17/3669.htm |
| Number | Citing Articles |
| 1 |
Snejina Vassileva, Valeria Mateeva, Kossara Drenovska. Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?. Clinics in Dermatology 2021; 39(3): 430 doi: 10.1016/j.clindermatol.2021.01.020
|
| 2 |
Simona Bogdanova. Musculoskeletal pain in patients with COVID-19. Rheumatology (Bulgaria) 2022; : 3 doi: 10.35465/30.2.2022.pp3-17
|
| 3 |
Giulia Costanzo, William Cordeddu, Luchino Chessa, Stefano Del Giacco, Davide Firinu. COVID-19: Considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemic. World Journal of Clinical Cases 2021; 9(20): 5352-5357 doi: 10.12998/wjcc.v9.i20.5352
|
| 4 |
Proceedings of the International Conference on Sustainable Innovation on Humanities, Education, and Social Sciences (ICOSI-HESS 2022). 2022; : 309 doi: 10.2991/978-2-494069-65-7_27
|
| 5 |
Rachele Francese, Massimo Rittà, David Lembo, Manuela Donalisio. Lupus and SARS-CoV-2: What have we learned after the pandemic?. Lupus 2025; 34(2): 117 doi: 10.1177/09612033241309845
|
| 6 |
Prajakta Warang, Gagandeep Singh, Mahan Moshir, Ornella Binazon, Gabriel Laghlali, Lauren A. Chang, Heidi Wouters, Peter Vanhoenacker, Margo Notebaert, Nadia Elhemdaoui, Kateřina Augustynková, Sophie Steeland, Peter Ulrichts, Judith Baumeister, Michael Schotsaert. Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models. Human Vaccines & Immunotherapeutics 2025; 21(1) doi: 10.1080/21645515.2025.2470542
|
| 7 |
Tsvetelina Velikova, Tsvetoslav Georgiev. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatology International 2021; 41(3): 509 doi: 10.1007/s00296-021-04792-9
|
| 8 |
Georgi Vasilev, Plamena Kabakchieva, Dimitrina Miteva, Hristiana Batselova, Tsvetelina Velikova. Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy. World Journal of Diabetes 2022; 13(9): 738-751 doi: 10.4239/wjd.v13.i9.738
|
| 9 |
Metodija Sekulovski, Simona Bogdanova-Petrova, Monika Peshevska-Sekulovska, Tsvetelina Velikova, Tsvetoslav Georgiev. COVID-19 related liver injuries in pregnancy. World Journal of Clinical Cases 2023; 11(9): 1918-1929 doi: 10.12998/wjcc.v11.i9.1918
|
| 10 |
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, Francois Philippart. Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?. Drugs 2023; 83(1): 1 doi: 10.1007/s40265-022-01803-2
|
| 11 |
Sehnaz Olgun Yıldızeli, Duygu Vezir, Canan Cimsit, Derya Kocakaya, Zeynep Mercanci, Baran Balcan, Onur Ermerak, Can Ilgin, Emel Eryuksel, Sait Karakurt. Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?. Cureus 2023; doi: 10.7759/cureus.37633
|